North America Hematuria Treatment Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2028 - COVID-19 Impact and Regional Analysis By Treatment (Drugs, Therapies, and Others), Indication (Urinary Tract Infections, Kidney Stones, Urethritis, Blood Cancer, Bladder Stones, Prostate Cancer, Cystitis, Trauma, Vigorous Exercise, Polycystic Kidney Disease, Endometriosis, and Menstruation), Type (Macroscopic Hematuria, Microscopic Hematuria, Idiopathic Hematuria, and Jogger’s Hematuria), End User (Hospitals, Clinics, and Ambulatory Surgical Centers, and Others)

No. of Pages: 158    |    Report Code: TIPRE00026252    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
North America Hematuria Treatment Market
Free Sample Buy Now

1. Introduction

1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Hypothesis formulation:
  • 3.2.2 Macro-economic factor analysis:
  • 3.2.3 Developing base number:
  • 3.2.4 Data Triangulation:
  • 3.2.5 Country level data:

4. North America Hematuria Treatment Market Landscape

4.1 Market Overview
4.2 Porter's Five Forces Analysis
  • 4.2.1 Bargaining Power of Suppliers
  • 4.2.2 Bargaining Power of Buyers
  • 4.2.3 Threat of New Entrants
  • 4.2.4 Competitive Rivalry
  • 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
  • 4.3.1 Raw Material Suppliers
  • 4.3.2 Manufacturers
  • 4.3.3 Distributors/Suppliers
  • 4.3.4 End Users

5. North America Hematuria Treatment Market – Key Market Dynamics

5.1 Growth Drivers
  • 5.1.1 Defined treatment algorithm of associated indications is propelling the market growth
5.2 Market Opportunities
  • 5.2.1 Growing awareness among the patients about the treatment is driving the hematuria treatment market.
5.3 Future Trends
  • 5.3.1 Rising prevalence of associated indications to open up opportunities in global hematuria treatment market
5.4 Impact of Drivers and Restraints

6. North America Hematuria Treatment Market Regional Analysis

6.1 North America Hematuria Treatment Market Overview
6.2 North America Hematuria Treatment Market Revenue 2019-2028 (US$ Million)
6.3 North America Hematuria Treatment Market Forecast Analysis

7. North America Hematuria Treatment Market Analysis – by Treatment

7.1 Drugs
  • 7.1.1 Overview
  • 7.1.2 Drugs: North America Hematuria Treatment Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Therapies
  • 7.2.1 Overview
  • 7.2.2 Therapies: North America Hematuria Treatment Market – Revenue and Forecast to 2031 (US$ Million)

8. North America Hematuria Treatment Market Analysis – by Indication

8.1 Urinary Tract Infections
  • 8.1.1 Overview
  • 8.1.2 Urinary Tract Infections: North America Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)
8.2 Kidney Stones
  • 8.2.1 Overview
  • 8.2.2 Kidney Stones: North America Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)
8.3 Urethritis
  • 8.3.1 Overview
  • 8.3.2 Urethritis: North America Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Blood Cancer
  • 8.4.1 Overview
  • 8.4.2 Blood Cancer: North America Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Bladder Stones
  • 8.5.1 Overview
  • 8.5.2 Bladder Stones: North America Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)
8.6 Prostate Cancer
  • 8.6.1 Overview
  • 8.6.2 Prostate Cancer: North America Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)
8.7 Cystitis
  • 8.7.1 Overview
  • 8.7.2 Cystitis: North America Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)
8.8 Trauma
  • 8.8.1 Overview
  • 8.8.2 Trauma: North America Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)
8.9 Vigorous Exercise
  • 8.9.1 Overview
  • 8.9.2 Vigorous Exercise: North America Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)
8.10 Polycystic Kidney Disease
  • 8.10.1 Overview
  • 8.10.2 Polycystic Kidney Disease: North America Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)
8.11 Endometriosis
  • 8.11.1 Overview
  • 8.11.2 Endometriosis: North America Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)
8.12 Menstruation
  • 8.12.1 Overview
  • 8.12.2 Menstruation: North America Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)

9. North America Hematuria Treatment Market Analysis – by Type

9.1 Macroscopic Hematuria
  • 9.1.1 Overview
  • 9.1.2 Menstruation: North America Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)
9.2 Microscopic Hematuria
  • 9.2.1 Overview
  • 9.2.2 Menstruation: North America Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)
9.3 Idiopathic Hematuria
  • 9.3.1 Overview
  • 9.3.2 Menstruation: North America Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Jogger's Hematuria
  • 9.4.1 Overview
  • 9.4.2 Menstruation: North America Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)

10. North America Hematuria Treatment Market – North America Analysis

10.1 North America
  • 10.1.1 North America Hematuria Treatment Market Breakdown, by Key Country, 2022 and 2028 (%)
  • 10.1.1.1 North America Hematuria Treatment Market – Revenue and Forecast Analysis – by Country
  • 10.1.1.1 US: North America Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.1.1 US: North America Hematuria Treatment Market Breakdown, by Treatment
    • 10.1.1.1.2 US: North America Hematuria Treatment Market Breakdown, by Indication
    • 10.1.1.1.3 US: North America Hematuria Treatment Market Breakdown, by Type
  • 10.1.1.2 Canada: North America Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.2.1 Canada: North America Hematuria Treatment Market Breakdown, by Treatment
    • 10.1.1.2.2 Canada: North America Hematuria Treatment Market Breakdown, by Indication
    • 10.1.1.2.3 Canada: North America Hematuria Treatment Market Breakdown, by Type
  • 10.1.1.3 Mexico : North America Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.3.1 Mexico : North America Hematuria Treatment Market Breakdown, by Treatment
    • 10.1.1.3.2 Mexico : North America Hematuria Treatment Market Breakdown, by Indication
    • 10.1.1.3.3 Mexico : North America Hematuria Treatment Market Breakdown, by Type

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. North America Hematuria Treatment Market Industry Landscape

12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 AstraZeneca
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 Bristol-Myers Squibb Company
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 F. HOFFMANN-LA ROCHE LTD.
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 GlaxoSmithKline plc.
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 Janssen Pharmaceuticals
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
13.6 Merck & Co., Inc.
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments
13.7 Novartis AG
  • 13.7.1 Key Facts
  • 13.7.2 Business Description
  • 13.7.3 Products and Services
  • 13.7.4 Financial Overview
  • 13.7.5 SWOT Analysis
  • 13.7.6 Key Developments
13.8 Pfizer Inc.
  • 13.8.1 Key Facts
  • 13.8.2 Business Description
  • 13.8.3 Products and Services
  • 13.8.4 Financial Overview
  • 13.8.5 SWOT Analysis
  • 13.8.6 Key Developments
13.9 Sun Pharmaceutical Industries Ltd
  • 13.9.1 Key Facts
  • 13.9.2 Business Description
  • 13.9.3 Products and Services
  • 13.9.4 Financial Overview
  • 13.9.5 SWOT Analysis
  • 13.9.6 Key Developments
13.10 Boehringer Ingelheim International GmbH
  • 13.10.1 Key Facts
  • 13.10.2 Business Description
  • 13.10.3 Products and Services
  • 13.10.4 Financial Overview
  • 13.10.5 SWOT Analysis
  • 13.10.6 Key Developments

14. Appendix

14.1 About Business Market Insights

The List of Companies - N Market

  1. AstraZeneca
  2. Bristol-Myers Squibb Company
  3. F. HOFFMANN-LA ROCHE LTD.
  4. GlaxoSmithKline plc.
  5. Janssen Pharmaceuticals
  6. Merck & Co., Inc.
  7. Novartis AG
  8. Pfizer Inc.
  9. Sun Pharmaceutical Industries Ltd
  10. Boehringer Ingelheim International GmbH
north-america-hematuria-treatment-market